Publications by authors named "B C"

The cultivation of nearly 10,000 indigenous rice landraces in the North-Eastern Hill (NEH) region by various ethnic groups creates opportunities for the utilization of unique landraces through systematic evaluation of genetic variability. In the present study, a set of 102 rice landraces were assessed based on morphological and SSR markers, and five checks in augmented design vis-à-vis high-yielding rice genotypes with stable performance were identified. The presence of high estimates of heritability, genotypic coefficient of variation, and genetic advance over mean indicated the predominance of additive gene action, which necessitated the effectiveness of selection in augmenting productivity.

View Article and Find Full Text PDF

Introduction: Hand injuries, particularly those involving the fingers, are complex and often necessitate meticulous surgical interventions. Cross-finger flaps (CFFs) are a reliable technique for covering finger defects, with the choice of skin graft at the donor site playing a crucial role in the procedure's success. Split-thickness skin grafts (STSGs) and full-thickness skin grafts (FTSGs) are commonly used, each offering distinct advantages and drawbacks.

View Article and Find Full Text PDF
Article Synopsis
  • HCV treatment has significantly improved with direct-acting antiviral therapy (DAA), allowing for shorter treatment durations and better tolerability in difficult-to-treat populations, such as people who inject drugs (PWID) and those on opioid substitution therapy (OST).
  • A retrospective analysis of patients receiving DAA at a clinic in Bonn showed that all patients on glecaprevir/pibrentasvir completed their treatment, while 86% of those on sofosbuvir/velpatasvir did, resulting in a 74% sustained virological response (SVR) overall, despite some patients being lost to follow-up.
  • The study highlights high adherence and SVR rates for HCV treatment in PWID, supporting efforts to
View Article and Find Full Text PDF
Article Synopsis
  • COVID-19 vaccination in Australia began in February 2021, with initial vaccines requiring two doses; booster vaccinations are now being recommended to maintain immunity.
  • The PICOBOO trial is a multi-site study that tests various COVID-19 booster vaccines in children and adults, looking at their effectiveness and safety across different vaccination histories and age groups.
  • This adaptive trial structure allows for rapid adjustments to research elements, helping to explore the best approaches for combating COVID-19 variants and assessing new vaccines as they are introduced.
View Article and Find Full Text PDF